Cristal Therapeutics
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy Study of CPC634 (CriPec® Docetaxel) in Platinum Resistant Ovarian Cancer (NCT03742713) | Cristal Therapeutics | 2018-10-01 |
Track Cristal Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.